Z-2259-2017 Class II Terminated
FDA device recall Z-2259-2017 was initiated by Arrow International Inc on March 20, 2017 and is designated Class II. Reason for recall: Arrow International initiated the recall due to reports of safety cover disengagement and needlestick injury for the BD Eclipse Needle that are packaged with certain Arrow products. The recall status is terminated (terminated December 18, 2018). Affected quantity: 43,394 units.
Recall Details
- Product Type
- Devices
- Report Date
- June 14, 2017
- Initiation Date
- March 20, 2017
- Termination Date
- December 18, 2018
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 43,394 units
Product Description
MAC(TM) Two-Lumen Central Venous Access Kit with ARROWg+ard Blue (R) Access Device, Integral Hemostasis Valve, Sharps Safety Features and Maximal Barrier Precautions for use with 7.5 -8 Fr. Catheters. The MAC(TM) Multi-Lumen Central Venous Access Device with ARROWg+ard Blue(R) permits venous access and catheter introduction to the central circulation. It may be inserted into the jugular, subclavian, or femoral veins. The ARROWg+ard(R) technology is intended to help provide protection against catheter-related infections. Clinical data have not been collected that demonstrate the use of the ARROWg+ard(R) antimicrobial surface in decreasing catheter-related infections for this device. It is not intended to be used as a treatment for existing infections, nor is it indicated for long-term use.
Reason for Recall
Arrow International initiated the recall due to reports of safety cover disengagement and needlestick injury for the BD Eclipse Needle that are packaged with certain Arrow products.
Distribution Pattern
Nationwide Distribution
Code Information
Material Number ASK-21142-HF2